5-HT6 pharmacology inconsistencies

Pharmacology Biochemistry and Behavior

Volumn 98, Issue 2, 2011, Pages 169-172

  Borsini, Franco ^a   Bordi, Fabio ^a   Riccioni, Teresa ^a  

^a Sigma Tau SpA   (Italy)

Author keywords

5HT6; MRNA; Neurochemistry and behavior; Receptors

Indexed keywords

4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; ACETYLCHOLINE; ATROPINE; DOPAMINE; HALOPERIDOL; IODINE 125; LYSERGIDE; N (3,5 DICHLORO 2 METHOXYPHENYL) 4 METHOXY 3 (1 PIPERAZINYL)BENZENESULFONAMIDE; PHYSOSTIGMINE; RO 65 7199; SB 258585; SB 357134; SB 699929; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT; TRITIUM; UNCLASSIFIED DRUG; LIGAND; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ANTICONVULSANT ACTIVITY; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; MASTICATION; NEUROCHEMISTRY; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RADIOASSAY; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; SEROTONIN BRAIN LEVEL; STRETCHING; YAWNING; ANIMAL; ANIMAL BEHAVIOR; BRAIN; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; HUMANS; LIGANDS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 78751644213     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.12.021     Document Type: Review

References (67)

1. 6 receptor antagonists Bioorg Med Chem Lett 15 2005 4867 4871 (Pubitemid 41354824)
2. J. Arnt, B. Bang-Anderson, B. Grayson, F.P. Bymaster, M.P. Cohen, N.W. DeLapp, B. Giethlen, M. Kreilgaard, D.L. McKinzie, J.C. Neill, D.L. Nelson, S.M. Nielsen, M.N. Poulsen, J.M. Schaus, and L.M. Witten LuAE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats Int J Nuropsychopharmacol 13 2010 1021 1033
3. 6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding J Psychopharmacol 11 1997 A64
4. 6 receptor antagonist, Ro04-6790, in rats Br J Pharmacol 126 1999 1537 1542 (Pubitemid 29182336)
5. 6 receptors stably expressed in HEK293 cells Neuropharmacology 36 1997 713 720 (Pubitemid 27272118)
6. 3H]Ro63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum Mol Pharmacol 54 1998 577 583 (Pubitemid 28442951)
7. F. Borsini, M.A. Stasi, P. Minetti, T. Riccioni, and T. Mennini Effect of ST1936, a 5HT6 ligand, on rodent adenylate cyclase and forced swimming test Int J Neuropsychopharmacol 11 Suppl. 1 2008 123 124
8. 6 receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides Eur J Med Chem 36 2001 165 178 (Pubitemid 32304518)
9. 6 receptor in the rat brain: a study using antisense oligonucleotides J Pharmacol Exp Ther 274 1995 173 180
10. 6 receptors as emerging targets for drug discovery Ann Rev Pharmacol 40 2000 319 334 (Pubitemid 30340685)
11. 6 receptor antagonist J Med Chem 42 1999 202 205 (Pubitemid 29069853)
12. S.M. Bromidge, S.E. Clarke, T. Gager, K. Griffith, P. Jeffrey, and A.J. Jenning Phenyl benzensulfonamides are novel and selective 5-HT6 antagonists: identification of N(2, 5-dibromo-3-fluorophenyl)-4-methoxy-3-pioperqzin-a- ylbenzensulfonamide (SB-357134) Bioorg Med Chem Lett 11 2001 55 58 (Pubitemid 32006123)
13. K.E. Burnham, M.G. Baxter, J. Bainton, E. Southam, L.A. Dawson, T. Sharp, and D.M. Bannerman The 5-HT6 receptor agonist WAY181187 enhances extradimensional set-shifting in the rat Br J Pharmacol 5 2 2007 27P
14. Carr GV, Schechter LE, Lucki I. Antidepressant and anxiolytic effects of selective 5-HT(6) receptor agonists in rats. Psychopharmacology 2010 Mar 9 doi:10.1007/s00213-010-1798-7 [Epub ahead of print].
15. Codony X, Burgueño, J, Ramírez MJ, Vela JM. 5-HT6 receptor signal transduction. Second Messenger Systems. Int Rev Neurobiol 2010;94:89-110.
16. 6 receptor agonists and antagonists J Med Chem 48 2005 353 356 (Pubitemid 40139779)
17. D.C. Cole, J.R. Stock, W.J. Lennox, R.C. Bernotas, J.W. Ellingboe, S. Boikess, J. Coupet, D.L. Smith, L. Leung, G.-M. Zhang, X. Feng, M.F. Kelly, R. Galante, P. Huang, L.A. Dawson, K. Marquis, S. Rosenweig-Lipson, Beyer, and L.E. Schechter Discovery of N1-(6-chloroimidazo[2, 1-b][1, 3]thiazole-5-sulfoyl) tryptamine as a potent, selective, and orally active 5-HT6 receptor agonist J Med Chem 50 2007 5535 5538 (Pubitemid 350106003)
18. 6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate Br J Pharmacol 130 2000 23 26 (Pubitemid 30248421)
19. 6 receptor-activation on rat brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression Neuroscience 147 2007 778 785 (Pubitemid 46990655)
20. 6 receptors: a comparative study of coupling to GαS Eur J Pharmacol 588 2008 170 177
21. 6 receptor in cognitive function Neuropharmacology 55 2008 1015 1022
22. 6 receptor antagonism potentiates the behavioural and neurochemical effects of amphetamine but not cocaine Neuropharmacology 42 2002 170 180 (Pubitemid 34137020)
23. 6 receptor antagonists for the treatment of Alzheimers disease Curr Top Med Chem 8 2008 1035 1048
24. W.J. Geldenhuys, and C.J. Van der Schyl The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimers disease Expert Rev Neurother 9 2009 1073 1085
25. R.A. Glennon, U. Siripurapu, B.L. Roth, R. Kolanos, M.L. Bondarev, and D. Sikazwe The medicinal chemistry of 5-HT(6) receptor ligands with a focus on arylsulfonyltryptamine analogs Curr Top Med Chem 10 2010 579 595
26. 6 receptors Neuropsychopharmacology 21 1999 68S 76S (Pubitemid 29396473)
27. 6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders Pharmacol Ther 117 2008 207 231
28. 6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimers disease Life Sci 84 2009 558 562
29. 6 receptors in rat, pig, and human brain tissue Br J Pharmacol 130 2000 1597 1605 (Pubitemid 30611937)
30. W.D. Hirst, B. Abrahamsen, F.E. Blaney, A.R. Calver, L. Aloj, and G.W. Price Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling Mol Pharmacol 64 2003 1295 1308 (Pubitemid 37532219)
31. 6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel recognition models Eur J Pharmacol 553 2006 109 119 (Pubitemid 44779592)
32. 6 receptor ligands as potential cognitive enhancers and antiobesity agents Drug Dis Today 11 2006 283 299
33. 6 receptor antagonists Bioorg Med Chem Lett 10 2000 1719 1721 (Pubitemid 30495247)
34. A.V. Ivachtchenko, O.D. Mitkin, S.E. Tkachenko, I.M. Okun, and V.M. Kysil 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4, 3-b]indoles as 5-HT6 receptor antagonists Eur J Med Chem 45 2010 782 789
35. 6 receptor antagonists: prospective for the treatment of cognitive disorders including dementia Curr Opin Drug Discov Dev 11 2008 642 654
36. I. Kendall, H.A. Slotten, X. Codony, J. Burgueno, P.J. Pauwels, J.M. Vela, and K.C.F. Fone E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat Psychopharmacology 2010 Pub ahead 20 April PMID: 20405281
37. 6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex Synapse 51 2004 158 164 (Pubitemid 38018798)
38. 6 receptor gene variations in healthy adults J Psychiatry Neurosci 33 2008 47 53 (Pubitemid 351252496)
39. 6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus Brain Res 1134 2007 70 78 (Pubitemid 46135533)
40. 6) receptor antagonists in rodent models of learning J Pharmacol Exp Ther 307 2003 682 691 (Pubitemid 37310684)
41. K.G. Liu, and A.J. Robichaud 5-HT6 antagonists as potential treatment for cognitive dysfunction Drug Dev Res 70 2009 145 168
42. 6 ligands Bioorg Med Chem 19 2009 2413 2415
43. D. Marazziti, L. Palego, A. Giromella, M.R. Mazzoni, F. Borsini, and N. Mayer Region-dependent effect of flibanserin and buspirone on adenylyl cyclase activity in the human brain Int J Neuropsychopharmacol 5 2002 131 140 (Pubitemid 34669828)
44. 6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat Br J Pharmacol 155 2008 434 440
45. C. Mattsson, C. Sonesson, A. Sandahl, H.E. Greiner, M. Gassen, J. Plaschke, J. Leibrock, and H. Bottcher 2-Alkyl-3-(1, 2, 3, 6-tetrahydropyridin- 4-yl)-1H-indoles as novel 5-HT6 receptor agonists Bioorg Med Chem Lett 15 2005 4230 4234 (Pubitemid 41187992)
46. 6 serotonin receptor-coupled adenylyl cyclase in stably transfected HEK-293 cells J Serotonin Res 2 1995 101 116
47. 2C receptors as target for the treatment of depressive and anxious states: focus on novel therapeutic strategies Therapie 5 2005 441 460
48. 6 receptors in rat nucleus accumbens by antisense oligonucleotides Neuroscience 92 1999 1001 1009 (Pubitemid 29287545)
49. C. Reavill, and D.C. Rogers The therapeutic potential of 5-HT6 receptor antagonists Curr Opin Investig Drugs 2 2001 104 109 (Pubitemid 32094011)
50. 6 receptor antagonist J Med Chem 46 2003 1273 1276 (Pubitemid 36428233)
51. 6 receptor antagonist Br J Pharmacol 130 2000 1606 1612 (Pubitemid 30611938)
52. 6 receptor ligand and their biological functions Curr Top Med Chem 2 2002 643 654
53. 6 receptor agonist Soc Neurosci Meeting 2004 394.11
54. 6 receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacology 33 2008 1323 1335 (Pubitemid 351521711)
55. S. Shirazi-Southall, D.E. Rodriguez, and G.G. Nomikos Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat Neuropsychopharmacology 26 2002 583 594 (Pubitemid 34260977)
56. 6 receptors Br J Pharmacol 1245 1998 556 562 (Pubitemid 28254513)
57. 6 receptor antagonists Pharmacol Biochem Behav 71 2002 645 654 (Pubitemid 34219215)
58. 6 receptor stimulation J Neurosci 27 2007 4201 4209 (Pubitemid 46597167)
59. 6 receptor antagonists Bioorg Med Chem Lett 18 2008 5698 5700
60. 6 agonist Behav Pharmacol 20 special issue 1 2009 S36
61. 6 receptor antagonist SB-399885 in rats Pharmacol Rep 59 2007 664 671 (Pubitemid 351586557)
62. 6 receptor antagonists SB-3999885 in animal models of anxiety and depression Neuropharmacology 52 2007 1274 1283 (Pubitemid 46527703)
63. 6 receptor antagonist SB-258585 after the intrahippocampal administration to rats Behav Pharmacol 18 2007 439 446 (Pubitemid 47356370)
64. 6 receptors in retention of spatial learning in the Morris water maze Neuropharmacology 41 2001 210 219 (Pubitemid 32728092)
65. 6 receptors Curr Drug Targets 3 2004 59 89
66. 6 receptor subtype in the rat brain Life Sci 62 1998 1473 1477 (Pubitemid 28210226)
67. 6 receptor ligands Bioorg Med Chem Lett 15 2005 1393 1396 (Pubitemid 40268999)